In postmenopausal women with osteoporosis, treatment with alendronate in combination with raloxifene has a more pronounced effect than either drug used alone, a small study shows.
Each medication by itself significantly increased bone mineral density and raloxifene had some beneficial effects on lipid metabolism, researchers found.
No significant differences were found in the incidence of adverse effects.
Climacteric 2011 online 23 January
Content updated 31 January 2011